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The structure of a genomic DNA fragment encoding mouse cathepsin B was characterized. The genomic insert spans 15 kbp and contains 9 exons 
encoding the 339 amino acid residues of mouse preprocathepsin B. Intron break-points are not found at the junctions of the pre-peptide, pro-peptide 
and mature enzyme. Like other cysteine proteinase genes, the region around the cysteinyl active site is split by an intron, but in contrast with 
cathepsins L and H the intron break-point is located immediately after the active site. 
Cathepsin B; Gene structure; Cysteine proteinase 
1. INTRODUCTION 
Members of the cysteine proteinase family include 
papain from papaya plant, aleurain from aleurone 
cells, proteinase CPl and CP2 from Dictyostelium 
discoideum and cathepsins B, H and L from mam- 
malian lysosomes [l-4]. Cathepsin B, together with 
cathepsins H and L, play an important role in in- 
tracellular protein catabolism [5] and may also be in- 
volved in tumor metastasis [6,7]. The primary structure 
of cathepsin B has been determined at the protein level 
VI and immunological investigations on post- 
translational processing of cathepsin B have shown that 
this proteinase is synthesized as a preproenzyme form 
[9-l 11. Cloning of the cDNA for cathepsin B has reveal- 
ed the structure of its primary translation product 
[ 12-141. Similar studies involving cDNA cloning have 
been reported for aleurain [3], rat cathepsin H [15] and 
rat cathepsin L [ 161. The gene structure of rat cathepsin 
H [ 171 and cathepsin L [ 181 have been described recent- 
ly. However, there is yet no data on cathepsin B gene 
structure. 
heim; Ban1 enzyme from Promega; T7 DNA polymerase sequencing 
kit from Pharmacia; (o-“P)dATP, (o-3sS)dATP, Hybond N ’ mem- 
brane and Hyper-films MP from Amersham. 
2.2. Methods 
2.2.1. Genomic library screening The genomic library used was 
from Clontech (BL 1011). It contained a partial Mb01 digest of mouse 
BALB/c genomic DNA cloned into the vector XEMBL3. We screened 
5 x lo5 plaque forming units (pfu) with the rat cDNA insert of the 
prCB3 clone (a generous gift of Chan and Steiner). This 1.15 kbp 
EcoRI insert was labeled by nick translation [19] to a specific activity 
of 2-4 x lo* dpm/pg. 
2.2.2. Subcloning and sequencing DNA inserts from one phage 
clones (x32) were digested with appropriate restriction enzymes and 
then subcloned into the pUCl8 and Ml3 phage vectors. DNA se- 
quences were determined by the dideoxynucleotide chain termination 
method of Sanger [20] using T7 DNA polymerase (Pharmacia). 
3. RESULTS 
3.1. Isolation, mapping and sequence analysis of 
cathepsin B gene 
In this paper, we report the gene structure of mouse 
cathepsin B and compare it with those of other cysteine 
proteinases. 
2. MATERIALS AND METHODS 
2.1. Materials 
The sources of materials used in this work are as follows: restriction 
enzymes from Bethesda Research Laboratory and Boehringer Mann- 
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We screened 5 x lo5 phages of the XEMBL3 mouse 
genomic library with the rat cathepsin B cDNA probe 
prCB3 [ 121. Restriction endonuclease mapping showed 
that among the 6 positive clones obtained, 5 clones were 
different and one of them (x32) was further characteriz- 
ed. Each digestion fragment which hybridized to the rat 
cDNA probe was separately subcloned into pUC18 
plasmid and for each subclone restriction maps were 
completed. Using Ml3 clones, Ba131 digestion and 10 
different oligonucleotide primers, the major part of the 
genomic clone X32 spanning 15 kbp was sequenced. The 
clone X32 contained all cathepsin B coding sequences. 
The structure of mouse cathepsin B gene, as revealed by 
restriction mapping, hybridization and DNA sequence 
analysis of X32, is presented in Fig. 1. 
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Fig. 1. Restriction map and schematic structure of mouse cathepsin B gene. The map was constructed from clone X32. Each intron is alphabetically 
named from 5 ‘ to 3 ’ end. Exons are represented by numbered filled areas. Arrows indicate direction and length of sequencing. Restriction enzyme 
sites are: B, BarnHI; Be;, BgZII; E, EcoRI; H, WindHI; P, PM; Sma, SQZQI; S, MI; X, XbaI. The structure of mouse cathepsin cDNA 1131 isalso 
shown. Solid bars indicate 5 ’ - and 3 ‘-non-coding regions. The coding regions for pre-peptide. pro-peptide and mature enzyme are represented by 
lightly dotted, heavily dotted and striped teetangles, respectively. 
3.2. Intron-exon structure 
Sequence analysis of the genomic clone X32 showed 
that it contains 9 exons and 8 introns spanning a region 
of approximately 9 kbp. The length of each exon varied 
from 86 bp (exons 2 and 5) to more than 250 bp in exon 
9 which size is not yet determined (Table I). A single in- 
itiation codon ATG is present in exon 1 which has a 15 
bp untranslated region corresponding to the 
3 I-terminal sequence of the mRNA leader. Exon 1 en- 
codes the signal peptide sequence of prepr~athepsin B. 
The propeptide region is encoded by exons 1-3 and ex- 
ons 3-9 encode the mature enzyme region. 
Table I 
Summary of mouse cathepsin B gene structure 
Exon Nucleotide number Size GC content 
in cDNA (bpf (o/o) 
1 126 (>141) 51a 
2 127 212 86 51 
3 213 327 11.5 53 
4 328 446 119 56 
5 447 532 86 48 
6 533 676 144 57 
7 617 793 117 45 
8 794 922 129 54 
9 923 (>250) 47b 
Nucleotide numbering of mouse cDNA starts at the initiation codon 
ATG. 
aThe genomic DNA fragment X32 starts within Exon 1 (nucleotide 
- 1.5 of mouse cDNA) and the exact size of this exon is not known 
(shown in parentheses). GC content was estimated for the 141 
nucleotides that were sequenced in exon 1 bThe exact size of exon 9 is 
not known {shown in parenth~~. GC content was estimated for the 
250 nucleotides that were sequenced in exon 9 
196 
Eleven differences in nucleoticre sequence were found 
between cDNA and genomic DNA when 1110 bp were 
compared (Table II). The majority of these differences 
located in coding region are silent changes. Four dif- 
ferences are causing an amino acid change: for 3 of 
them the ‘new’ amino acid corresponds to the rat or the 
man cathepsin B sequence; only the guanine-479 which 
was adenine in the cDNA causes an amino acid change 
from Asn to Ser not found in the other cathepsin B pro- 
teins. These differences could be due to sequence 
polymorphism. 
3.3. Axon-intron boundary sequence 
Eight intron-exon boundary sites were determined 
and are shown in Table III. They were all in agreement 
with the GT/AG consensus rule [21]. For the cathepsin 
B gene, the intron splice phase [22] is type I for introns 
E, F, G and H (the intron interrupts the first and second 
bases of the codon), type II for introns B and D (the in- 
tron interrupts the second and third bases of the 
codon), and type 0 for introns A and C (this intron oc- 
curs between codons). 
4. DISCUSSION 
In this report we characterize the genomic structure 
of mouse cathepsin B gene. The clone (x32) isolated 
contains all exons corresponding to the cDNA sequence 
except the leader region. So, this clone is defined as 
mouse cathepsin B gene. The gene analysed, containing 
at least 9 exons spanning approximately 9 kbp, shows 
the restricted size ~stribution typical for the most 
eukaryotic genes. A common characteristic observed 
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Table II 
Differences in nucleotide sequences between the cDNA and the genomic DNA 
EXOll 
4 
.5 
6 
8 
9 
cDNA nucleotide cDNA Amino acid residue Genomic DNA Amino acid residue Total difference in 
number exon (%) 
429 OGC GUY GOT GUY 0.84 
479 AAC Asn AQC Serb 
520 CAT Asp AAT AsnS 3.49 
529 ATA Ife 0-l-A Vaf” 
543 CCQ Pro CC& Pro 
591 CCQ Pro CC.& Pro 
594 TGT CYs TOG cys 3.47 
600 GGQ GUY GGA GUY 
603 GAG G1I.l GAA Glu 
851 GTC Val CQC GW 0.78 
948 GAL?& GlU GAQ GlU WzO 
‘Amino acid residue found in rat or in human cathepsin 3 protein 
‘Amino acid residue not found in any cathepsin B protein so far examined 
‘The sequence published for mouse cathepsin B cDNA IiS] encompasses only 191 bp of exon 9 
for the gene structures of ait cysteine proteinases o far 
examined (aleurain, CPl, CP2, cathepsins H, L) is that 
intron break-points are not found at the junctions of 
the pre-peptide, pro-peptide and mature enzyme 
regions. Accordingly, there is no evidence that the gene 
structure of cathepsin B corresponds to functional units 
(Fig. 2). 
Important differences nevertheless distinguish gene 
structures of cysteine proteinases, Number and position 
of introns vary between cysteine proteinases. The genes 
encoding rat cathepsin H fly], rat cathepsin L f Is], 
aleurain 1211, CPl and CP2 1241 contain 12, g,7, 5 and 
4 introns, respectively, while the gene structure of 
mouse cathepsin B revealed at least 9 introns. In cathep- 
sin B and H genes 5 introns interrupt the two active site 
Cys- and His-residues, instead of 2 in cathepsin L and 
CPI, 3 in afeurain and 1 in CP2 genes (Fig, 2)_ The 
region around the cysteinyl active site (Cys-29 in 
cathepsin B), which is highly conserved among cysteine 
proteinases, is always closed to an intron-exon junc- 
tion, However, in cathepsin B and aleurain genes this 
junction is located immediately after the conserved se- 
quence (Fig. 2) while in cathepsin H, cathepsin L and 
CP I this junction is located immediately before. In CP2 
gene an intron-exon junction interrupts the active site 
sequence [23]. The critical differences in both nlunber 
and position of introns between cysteine proteinase 
genes supports the notion that the relation between the 
genes is not direct. 
Because amino acid sequences of cysteine proteinases 
display a high degree of identity between each other, 
essentially in amino and carboxy terminal regions (con- 
Table III 
Splice junctions of the mouse cathepsin B gene 
coirscnsUs S’donor AG*g taag t ..*..... . ..lVS . . . . . . . . . . . ~PPppppppcag’ f’acceptor 
I 
NSA 
NSE 
NSC 
NSD 
NSE 
IVS F 
IVS G 
xvs H 
TGG CAG * g I B g g c ..__ _ . . . . IYSA ..__ . . . . ..a c t c t c t f I c ag *GCT GOA CGC 
Trp Gin 
CCA GGA 
Alrt Gty Arg 
AG* g t g a g t _......_.. IVSB .r . . . . . . ..t c t t t t gee t ag*G GTT GCG 
Pro Giy Ar g V&f Ala 
TOT TOG’ g t B P g c _........ NSC ,......,. 1 ata!trccacag*GCA TTT 000 
Cyr Trp Ala Phe Glu 
GGG GAC GG*g tg ag t . . . . . . . . . . NSD . . . . . . . . ..I c t c t t t t t c ag’C TGT AA1 
Gly Asp 01 y Cys Asn 
CAT GTA G*g tg ag t . . . . . . . . . . NSE . . . . . ..n.. t cc I t c tg t c ag*GC TGC TTA 
His V&l G ly cys LCU 
CAC TTT G’g t a ag c . . . . . . . . . . NSF . ...“..... fttcttttncag*GG TAC ACT 
His Phe G 
AAA TCA 
ly Tyr Thr 
G+ g t me c a . ..I..... NSG. 1.1.1.” ..t t t c t t c t t c ag *GA GTA TAC 
Lys Ser G ly Vnl Tyr 
GAT AAT G*g tg ag t . . . . . . . . . . NSH. . . . . ...“. 1 c t eta t ccc ag*GC TTC TTT 
Aso Am G Iv Phe Phe 
The consensus equence- for splice donor and acceptor site is shown on the top line {p = pyr~midine-). The residues ~round~~ the plice donor and 
acceptor sites for each cathepsin B exon are indicated. Note that the splice phase of irttrons A and C are type 0, the phases of introns E to R are 
type I, and the phases of intrcm B and D are type If. The exon sequences are shown in upper case letters; the intron sequences in lower case. 
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Fig. 2. Comparison of intron position in cysteine proteinases. Amino acid sequences of rat cathepsin H 1171, rat cathepsin L [18], aleurain [21], 
CPl and CP2 1241 are aligned for maximum identity to that of mouse cathepsin B. Amino acids are numbered starting from the N-terminus of 
the mature enzyme region of mouse cathepsin B. Negative numbers indicate pre- and pro-peptides regions. Arrows indicate intron insertion 
positions. Asterisks show the active site Cys- and His-residues, 
taining the active site Cys- and His-residues, respective- 
ly [8,16]), it has initially been hypothesized [25] that 
eysteine proteinases derive from a common ancestral 
gene. In fact, judging from the gene structure and GC 
content of exons, Whittier et al. [24] have then sug- 
gested that the aleurain gene arose by fusion of 2 
ancestral genes. Ishidoh et al. 1171 have further propos- 
ed that cathepsin H gene is composed of 4 rather than 
2 ancestral gene segments. For cathepsin B gene, the GC 
content of different exons is more homogeneous (see 
Table I) than for cathepsin H [ 171, cathepsin L [ 181 and 
aleurain [24]. In contrast to aleurain and cathepsins H 
and L, it is then difficult to ascribe different origins to 
the different exons of cathepsin B. We can only point 
out that the cathepsin B exon encoding the histidyl ac- 
tive site is 54% GC rich like the aleurain corresponding 
exon (55%) which is appreciably different from the cor- 
responding exons in cathepsin L ~43~0) and cathepsin H 
(44Yo) (Table IV). 
To discuss the relative variability of different regions 
of a protein family a functional divergence ratio (FDR) 
was defined by Creighton and Dardy [26] as ‘the fre- 
quency of mutations that cause amino acid replacement 
at positions within the functions region of a protein 
relative to the frequency of replacement within the re- 
mainder of the protein’. Unlike the other protease fami- 
ly, the members of the cysteine proteinase family do not 
exhibit hypervariability of active site amino acid se- 
quence [26]. This low FDR value observed for cathep- 
sins reflects the preferential conservation during evolu- 
tion of the functional region containing cysteine residue 
directly involved in the catalytic site of the enzyme. The 
comparison of cysteine proteinase gene structures 
demonstrates that the very conserved cysteinyl active 
site sequence has probably evolved in several ways. This 
confirms the essential role of this region for hydrolysing 
activity of cysteine proteinase and the critical role that 
cysteine proteinases play in vivo. 
Table IV 
Exon encoding 
Comparison between cysteine proteinase of the GC content of exons encoding active site regions 
Mouse cathepsin B Rat cathepsin L Rat cathepsin H Aleurain 
@o) (%I WJO) W] 
Cysteinyl active site 53 48 58 60 
Histidvl active site 54 43 44 55 
198 
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This report is, to our knowledge, the first d~cription 
of cathepsin B gene structure. The region upstream the 
ATG initiation codon remains to be analysed. As 
reported before (see section 3), we have isolated four 
other clones by stringent screening of XEMBL3 genomic 
library with prCB3 insert. Restriction maps for these 
clones are clearly different from X32 map. The analysis 
of these clones are in progress, but they already suggest 
the existence of several related cathepsin B gene se- 
quences in BALB/c mouse genome. 
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